Drug-induced lupus erythematosus epidemiology and demographics

Drug-induced lupus erythematosus Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Drug-induced lupus erythematosus from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Drug-induced lupus erythematosus epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Drug-induced lupus erythematosus epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Drug-induced lupus erythematosus epidemiology and demographics
CDC on Drug-induced lupus erythematosus epidemiology and demographics
Drug-induced lupus erythematosus epidemiology and demographics in the news
Blogs on Drug-induced lupus erythematosus epidemiology and demographics
Directions to Hospitals Treating Drug-induced lupus erythematosus
Risk calculators and risk factors for Drug-induced lupus erythematosus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Prevalence

• In the U.S.: As many as 10% of the approximately 500,000 cases of SLE may be DIL.
• It is estimated that 6 to 12% of all SLE cases are of drug-induced lupus type. The incidence has been reported to be of 15,000 to 30,000 per year in the U.S..

Case-Fatality Rate

• There is no information about case-fatality rate on drug-induced lupus, but it can be potentially fatal. 16466117

Age

Patients with DILE tend to be older (50–70 years old) than those with SLE (average age 29 years at diagnosis). Elderly persons generally are more susceptible to DILE.

Gender

In DIL, no significant statistical difference is apparent in the prevalence for males versus females. In contrast, SLE affects women with considerably higher frequency than men (female-to-male ratio of 9:1).

Ethnicity

More whites than blacks develop DIL; more blacks than whites present with SLE.

References

Template:WikiDoc Sources